Results 91 to 100 of about 1,292 (153)

The development of mucous membrane epidermolysis bullosa acquisita in a pediatric patient. [PDF]

JAAD Case Rep, 2021
Rentfro K, Arthur M.
europepmc   +1 more source

Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita. [PDF]

Front Immunol, 2022
Haeger SC, Kridin K, Pieper M, Griewahn L, Nimmerjahn F, Zillikens D, König P, Ludwig RJ, Hundt JE.   +8 more
europepmc   +1 more source

An atypical case of pediatric epidermolysis bullosa acquisita: Review of diagnosis and pitfalls. [PDF]

JAAD Case Rep, 2021
Patel A, Wanat K, Lalor L.
europepmc   +1 more source

Preventive but Not Therapeutic Topical Application of Local Anesthetics Can Inhibit Experimental Epidermolysis Bullosa Acquisita in Mice. [PDF]

Front Immunol, 2021
Wen L, Dong X, Li Q, Schramm G, Zhang B, Zillikens D, Ludwig RJ, Petersen F, Yu X.   +8 more
europepmc   +1 more source

Recalcitrant epidermolysis bullosa acquisita treated with upadacitinib as a bridge to rituximab. [PDF]

JAAD Case Rep
Rasul T, Concilla A, Militello M, Torres P, Stepien A.   +4 more
europepmc   +1 more source

Case report: Epidermolysis bullosa acquisita following dipeptidyl peptidase-4 inhibitor therapy and complicated by immune thrombocytopenic purpura. [PDF]

Front Immunol
Kawamoto H, Sasaki N, Ueda Y, Ishii N, Sawada Y.   +4 more
europepmc   +1 more source

The Retinoid Tamibarotene Aggravates Skin Inflammation in a Model of Bullous Pemphigoid-like Epidermolysis Bullosa Acquisita. [PDF]

Cells
Thieme M, Schilf P, Murthy S, Gonther S, Hammers CM, Heine G, Sadik CD.   +6 more
europepmc   +1 more source

Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita. [PDF]

Front Med (Lausanne), 2021
Zillikens H, Kasprick A, Osterloh C, Gross N, Radziewitz M, Hass C, Hartmann V, Behnen-Härer M, Ernst N, Boch K, Vidarsson G, Visser R, Laskay T, Yu X, Petersen F, Ludwig RJ, Bieber K.   +16 more
europepmc   +1 more source

Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita.

JAMA Dermatol, 2021
Becker M, Schumacher N, Schmidt E, Zillikens D, Sadik CD.   +4 more
europepmc   +1 more source

Epidermolysis bullosa acquisita: diagnostic difficulties

Przegląd Dermatologiczny
Izabela Staniszewska, Julia Lanckorońska, Agnieszka Kalińska-Bienias   +2 more
doaj   +1 more source